Global Virtual Biopsy Market Analysis 2025–2029: Opportunities for Strategic Growth

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Much Larger Is The Virtual Biopsy Market Expected To Become By 2029 Compared With Its 2025 Level?

The valuation of the virtual biopsy sector has seen substantial recent expansion, projected to climb from its 2024 figure of $0.63 billion to $0.71 billion by 2025, indicating a compound annual growth rate (CAGR) of 11.4%. This historical upward trajectory is fundamentally driven by several key factors: a heightened need for diagnostic procedures that avoid surgical intervention, a stronger inclination towards identifying illnesses at their earliest stages, improvements in the efficacy of medical visualization software, enhanced ease and comfort for patients undergoing assessments, and the broader accessibility of remote healthcare solutions.

Anticipation is for swift expansion within the realm of virtual biopsy over the immediate future, projecting a market valuation reaching $1.11 billion by the year 2029, which signifies a compound annual growth rate (CAGR) of 11.8%. This surge throughout the projected timeframe is fundamentally driven by several key factors: an increased emphasis on healthcare solutions that offer greater cost-efficiency, a heightened commitment to proactive health monitoring strategies, the escalating requirement for customized medical treatments, a rising proclivity for non-invasive cancer interventions, and the ever-increasing significance placed upon oncology practices characterized by high accuracy. Furthermore, noteworthy developments shaping this period involve advancements in imaging sensor technology, the creation of combined biopsy methodologies, the incorporation of robotic systems to boost exactitude, novel approaches to identifying biomarkers without surgical intrusion, and the incorporation of visualization aids that process three-dimensional data.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24424&type=smp

Which Drivers Are Supporting Growth Of The Virtual Biopsy Market?

The escalating incidence of cancer-related illnesses is anticipated to fuel the expansion of the virtual biopsy sector in the near future. Cancer, characterized by the uncontrolled multiplication and dissemination of aberrant cells, represents significant health challenges, and its growing frequency is largely attributable to shifts in modern living, including suboptimal nutrition, sedentary habits, tobacco consumption, and greater contact with environmental toxins. Virtual biopsy technology substantially aids in the detection and tracking of these oncological conditions, offering non-invasive, immediate visual data that lessens reliance on conventional tissue sampling while simultaneously boosting precision and ensuring better patient outcomes. To illustrate this trend, data released in July 2024 by the Australian Institute of Health and Welfare, a governmental body in Australia, indicated that cancer diagnoses in the country climbed to 160,570 across the year 2022, signifying a jump of 3,789 from the 156,781 cases documented in 2021; consequently, this upward trend in cancer occurrences is serving as a key motivator for the expansion of the virtual biopsy market.

What Are The Segment Types Shaping The Virtual Biopsy Market?

The virtual biopsymarket covered in this report is segmented –

1) By Target Thrapeutic Areas: Oncological Disorders, Neurological Disorders, Cardiovascular Disorders, Ophthalmological Disorders, Endocrine Disorders, Gastrointestinal Disorders, Other Target Therapeutic Areas

2) By Cancer Targeted: Solid Malignancies, Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Brain Cancer, Other Cancer Targeteds

3) By Imaging Technologies: Magnetic Resonance Imaging, Computed Tomography, X-Ray, Ultrasound, Other Imaging Technologies

4) By End Users: Hospitals And Clinics, Research Institutes And Diagnostic Centers, Other End Users

Subsegments:

1) By Oncological Disorders: Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, Liver Cancer, Brain Tumors, Other Cancers

2) By Neurological Disorders: Alzheimer’s Disease, Parkinson’s Disease, Multiple Sclerosis, Epilepsy, Brain Injuries, Stroke, Other Neurological Conditions

3) By Cardiovascular Disorders: Coronary Artery Disease, Heart Failure, Arrhythmias, Aortic Aneurysm, Valvular Heart Disease, Myocardial Infarction, Other Cardiovascular Conditions

4) By Ophthalmological Disorders: Age-Related Macular Degeneration, Diabetic Retinopathy, Glaucoma, Retinal Vein Occlusion, Cataracts, Other Eye Disorders

5) By Endocrine Disorders: Diabetes Mellitus, Thyroid Disorders, Adrenal Gland Disorders, Pituitary Gland Disorders, Parathyroid Disorders, Other Endocrine Conditions

6) By Gastrointestinal Disorders: Inflammatory Bowel Disease, Colorectal Polyps, Gastric Ulcers, Liver Cirrhosis, Pancreatic Disorders, Hepatitis, Other Gastrointestinal Conditions

7) By Other Target Therapeutic Areas: Musculoskeletal Disorders, Renal Disorders, Pulmonary Disorders, Hematologic Disorders, Dermatological Disorders, Infectious Diseases, Other Miscellaneous Conditions

Which Trends Are Impacting The Virtual Biopsy Market?

Leading entities within the virtual biopsy sector are concentrating efforts on engineering sophisticated technological capabilities and securing necessary regulatory clearances, exemplified by systems like the magnetic resonance spectroscopy (MRS) offering, with the objective of elevating the precision of non-invasive diagnoses and delivering immediate analytical feedback crucial for the early identification of ailments and tailoring patient therapies.MRS stands as a technique employing non-surgical imaging principles to augment virtual biopsy procedures by furnishing in-depth molecular data from biological tissues, thus permitting precise, immediate identification and tracking of diseases, circumventing the requirement for intrusive operations. Illustratively, in the eleventh month of 2023, the American health technology firm known as BrainSpec Inc. successfully obtained authorization from the United States Food and Drug Administration (FDA) for its platform, the BrainSpec, which incorporates artificial intelligence (AI). This particular innovation leverages sophisticated AI evaluation of MRS data to quantify neuro-metabolites like 2-hydroxyglutarate, thereby enabling non-penetrative virtual biopsies for diagnostic purposes across various pathologies including gliomas, Alzheimer’s disease, and multiple sclerosis. The framework is designed for smooth integration with conventional magnetic resonance imaging (MRI) equipment, automatically handles the data computation, and produces outcomes in mere minutes, further leveraging a repository of normal brain chemistry profiles to boost diagnostic reliability.

Which Leading Players Are Enhancing Their Virtual Biopsy Market Presence Worldwide?

Major companies operating in the virtual biopsy market are Canon Inc., Siemens Healthineers AG, GE Healthcare, Quest Diagnostics Incorporated, Olympus Corporation, Hologic Inc., Illumina Inc., Guardant Health Inc., Esaote S.p.A, Samsung Medison Co Ltd., Telix Pharmaceuticals Limited, Freenome Holdings Inc., Perspectum Ltd., QUIBIM S.L, IQ-AI Limited, BrainSpec Inc., Oncoustics Inc, ImageBiopsy Lab GmbH, AI Metrics LLC, Deep Bio Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/virtual-biopsy-global-market-report

Which Region Shows The Highest Potential For Future Expansion In The Virtual Biopsy Market?

North America was the largest region in the virtual biopsy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the virtual biopsy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Virtual Biopsy Market Report:

https://www.thebusinessresearchcompany.com/customise?id=24424&type=smp

Browse Through More Reports Similar to the Global Virtual Biopsy Market 2025, By The Business Research Company

Liquid Biopsy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/liquid-biopsy-global-market-report

Biopsy Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/biopsy-devices-global-market-report

Biopsy Devices Market 2025

https://www.thebusinessresearchcompany.com/report/biopsy-devices-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795